The U.S. Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM) has issued warning letters to three companies—Bailey’s Wellness, Holista, and House of Alchemy-Hamet & Love—for illegally selling unapproved cannabis-derived products for animals.
The letters, issued April 7, state the companies violated the federal Food, Drug, and Cosmetic Act by marketing various CBD-containing products, including oils, chews, and pellets, with unproven claims of health benefits across their websites and social media. The FDA has not approved these products as safe and effective for their intended use in animals.
The agency expressed particular concern over unapproved CBD products sold for food-producing animals. The FDA warned that there is a lack of data on how CBD residues might accumulate in "the human food (meat, milk, and eggs) derived from those animals," raising safety concerns for human consumers.
The companies were given 15 working days to outline how they will correct the violations and prevent them from recurring. Failure to comply could result in further legal action, including product confiscation or court injunctions, according to the FDA's announcement.
